These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19757026)

  • 1. Multimeric bivalent immunogens from recombinant tetanus toxin HC fragment, synthetic hexasaccharides, and a glycopeptide adjuvant.
    Bongat AF; Saksena R; Adamo R; Fujimoto Y; Shiokawa Z; Peterson DC; Fukase K; Vann WF; Kovác P
    Glycoconj J; 2010 Jan; 27(1):69-77. PubMed ID: 19757026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping the glycation sites in the neoglycoconjugate from hexasaccharide antigen of Vibrio cholerae, serotype Ogawa and the recombinant tetanus toxin C-fragment carrier.
    Jahouh F; Xu P; Vann WF; Kováč P; Banoub JH
    J Mass Spectrom; 2013 Oct; 48(10):1083-90. PubMed ID: 24130011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoglycoconjugates from synthetic tetra- and hexasaccharides that mimic the terminus of the O-PS of Vibrio cholerae O:1, serotype Inaba.
    Ma X; Saksena R; Chernyak A; Kovác P
    Org Biomol Chem; 2003 Mar; 1(5):775-84. PubMed ID: 12929359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One-pot preparation of a series of glycoconjugates with predetermined antigen-carrier ratio from oligosaccharides that mimic the O-PS of Vibrio cholerae O:1, serotype Ogawa.
    Saksena R; Ma X; Kovác P
    Carbohydr Res; 2003 Nov; 338(23):2591-603. PubMed ID: 14670719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conjugate Vaccines from Bacterial Antigens by Squaric Acid Chemistry: A Closer Look.
    Xu P; Kelly M; Vann WF; Qadri F; Ryan ET; Kováč P
    Chembiochem; 2017 Apr; 18(8):799-815. PubMed ID: 28182850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on vaccines against cholera. Synthesis of neoglycoconjugates from the hexasaccharide determinant of Vibrio cholerae O:1, serotype Ogawa, by single-point attachment or by attachment of the hapten in the form of clusters.
    Zhang J; Kovác P
    Carbohydr Res; 1999 Oct; 321(3-4):157-67. PubMed ID: 10614066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of synthetic saccharide fragments of Vibrio cholerae O1 (Ogawa and Inaba) bound to Exotoxin A.
    Wade TK; Saksena R; Shiloach J; Kovác P; Wade WF
    FEMS Immunol Med Microbiol; 2006 Nov; 48(2):237-51. PubMed ID: 17010106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of saccharide length on the immunogenicity of neoglycoconjugates from synthetic fragments of the O-SP of Vibrio cholerae O1, serotype Ogawa.
    Saksena R; Ma X; Wade TK; Kovác P; Wade WF
    Carbohydr Res; 2005 Oct; 340(14):2256-69. PubMed ID: 16098493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoenzymatic synthesis of immunogenic meningococcal group C polysialic acid-tetanus Hc fragment glycoconjugates.
    McCarthy PC; Saksena R; Peterson DC; Lee CH; An Y; Cipollo JF; Vann WF
    Glycoconj J; 2013 Dec; 30(9):857-70. PubMed ID: 23949787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Cholera Conjugate Vaccine Containing O-specific Polysaccharide (OSP) of V. cholerae O1 Inaba and Recombinant Fragment of Tetanus Toxin Heavy Chain (OSP:rTTHc) Induces Serum, Memory and Lamina Proprial Responses against OSP and Is Protective in Mice.
    Sayeed MA; Bufano MK; Xu P; Eckhoff G; Charles RC; Alam MM; Sultana T; Rashu MR; Berger A; Gonzalez-Escobedo G; Mandlik A; Bhuiyan TR; Leung DT; LaRocque RC; Harris JB; Calderwood SB; Qadri F; Vann WF; Kováč P; Ryan ET
    PLoS Negl Trop Dis; 2015; 9(7):e0003881. PubMed ID: 26154421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic fragments of Vibrio cholerae O1 Inaba O-specific polysaccharide bound to a protein carrier are immunogenic in mice but do not induce protective antibodies.
    Meeks MD; Saksena R; Ma X; Wade TK; Taylor RK; Kovác P; Wade WF
    Infect Immun; 2004 Jul; 72(7):4090-101. PubMed ID: 15213154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Production of recombinant fragments of the Clostridium tetani neurotoxin for the development of new immune-prophylaxis preparations against tetanus].
    Varfolomeeva NA; Makhotina OA; Sergeeva TI; Belyĭ IuF
    Mol Gen Mikrobiol Virusol; 2003; (3):29-33. PubMed ID: 12966924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conjugation of Synthetic Oligosaccharides to Proteins by Squaric Acid Chemistry.
    Pfister HB; Lu X; Soliman SE; Kováč P
    Methods Mol Biol; 2019; 1954():77-88. PubMed ID: 30864125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of eight glycosides of hexasaccharide fragments representing the terminus of the O-polysaccharide of Vibrio cholerae O:1, serotype Inaba and Ogawa, bearing aglycons suitable for linking to proteins.
    Ogawa Y; Lei PS; Kovác P
    Carbohydr Res; 1996 Oct; 293(2):173-94. PubMed ID: 8938375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Production and immunogenicity analysis of conformation-stable fragment-C mutant of tetanus toxin].
    Yu R; Hou L; Liu S; Yu C; Zhang X; Liu Y; Chen W
    Sheng Wu Gong Cheng Xue Bao; 2011 Feb; 27(2):226-32. PubMed ID: 21650047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic peptide antigens of tetanus toxin.
    Fischer PM; Howden ME
    Mol Immunol; 1994 Oct; 31(15):1141-8. PubMed ID: 7935502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The preparation of neoglycoconjugates containing inter-saccharide phosphodiester linkages as potential anti-Leishmania vaccines.
    Routier FH; Nikolaev AV; Ferguson MA
    Glycoconj J; 1999 Dec; 16(12):773-80. PubMed ID: 11133017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic neoglycoconjugates of cell-surface phosphoglycans of Leishmania as potential anti-parasite carbohydrate vaccines.
    Nikolaev AV; Sizova OV
    Biochemistry (Mosc); 2011 Jul; 76(7):761-73. PubMed ID: 21999537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell surface-exposed tetanus toxin fragment C produced by recombinant Bacillus anthracis protects against tetanus toxin.
    Mesnage S; Weber-Levy M; Haustant M; Mock M; Fouet A
    Infect Immun; 1999 Sep; 67(9):4847-50. PubMed ID: 10456940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization of mice against tetanus with fragments of tetanus toxin synthesized in Escherichia coli.
    Fairweather NF; Lyness VA; Maskell DJ
    Infect Immun; 1987 Nov; 55(11):2541-5. PubMed ID: 3312002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.